Infliximab Better than Oral DMARDs as Add-On to Methotrexate in Arthritis, Karolinska University Hospital And Karolinska Institute Study

Bookmark and Share

MedPage Today -- Putting rheumatoid arthritis patients on additional oral disease-modifying drugs when they show poor response to methotrexate in the disease's early stages did not work as well as adding infliximab (Remicade) in an open-label, randomized trial.

Back to news